Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending November 2012. The report details a specific share repurchase transaction executed on November 15, 2012, pursuant to shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 630,000 Ordinary Shares of 25 pence each.
- Purchase Date: November 15, 2012.
- Price Range: Highest price paid was 1,330.25 pence per share; lowest price paid was 1,317.50 pence per share.
- Treasury Holdings (Settled): 528,915,427 shares (9.71% of total issued share capital).
- Treasury Holdings (Including Unsettled): 530,140,427 shares (10.78% of total voting rights).
- Shares in Issue (Excluding Treasury): 4,916,631,394 shares.
Material Changes
The primary material change reported is the reduction of outstanding share capital through the cancellation of 630,000 repurchased shares. Consequently, the total number of shares held in treasury increased, raising the percentage of total voting rights held by the company to 10.78% when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the standard disclosure that the announcement does not constitute an offer to purchase securities. The transaction was conducted in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares in issue (4,916,631,394) for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the updated treasury share count (530,140,427 including unsettled) to assess the company's stake in its own voting rights.
- Note that the repurchased shares are cancelled, permanently reducing the share count.
- Acknowledge that this filing does not contain operational or financial performance data for the period.